Curi RMB Capital’s Caribou Biosciences CRBU Stock Holding History

Curi RMB Capital’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-153,964	Closed	-$253K	–	546
2024 Q2	$253K	Buy	153,964 +60,705	+65%	+$194K	0.01%	493
2024 Q1	$479K	Buy	93,259 +16,909	+22%	+$104K	0.01%	441
2023 Q4	$437K	Hold	76,350	–	–	0.01%	400
2023 Q3	$365K	Buy	76,350 +1,721	+2%	+$10.7K	0.01%	407
2023 Q2	$317K	Hold	74,629	–	–	0.01%	423
2023 Q1	$396K	Buy	74,629 +21,861	+41%	+$136K	0.01%	391
2022 Q4	$331K	Sell	52,768 -22,019	-29%	-$196K	0.01%	405
2022 Q3	$789K	Buy	+74,787	New	+$697K	0.03%	308

Other funds holding CRBU

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

EWM

Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Curi RMB Capital's CRBU Position: Q3 2024 in Review

Curi RMB Capital sold out of Caribou Biosciences (CRBU) in Q3 2024, closing a stake of 153,964 shares — an estimated $253K sold.

Curi RMB Capital first reported a position in CRBU in Q3 2022 and held it in 8 quarters. The position peaked at $789K in Q3 2022. 129 funds tracked by Wall St. Rank hold CRBU as of Q3 2024.

Curi RMB Capital reported no remaining Caribou Biosciences position as of Q3 2024 after selling out during the quarter.
Curi RMB Capital sold 153,964 Caribou Biosciences shares in Q3 2024, an estimated $253K.
Curi RMB Capital first reported a position in Caribou Biosciences in Q3 2022 and held it in 8 quarters.
Curi RMB Capital's Caribou Biosciences position peaked at $789K in Q3 2022.
129 funds tracked by Wall St. Rank held Caribou Biosciences as of Q3 2024.

Based on Curi RMB Capital's 13F filing for Q3 2024, filed 6 Nov 2024.